Brain cancer and leukemia are the most common cancers diagnosed in the pediatric
population and are often treated with lifesaving chemotherapy. However, chemotherapy …

Chemotherapy forms the backbone of treatment for many types of pediatric cancers, but a
main side effect of treatment is chemotherapy-induced peripheral neuropathy (CIPN) …

This systematic review provides a high-quality synthesis of the empirical evidence regarding
chemotherapy-induced peripheral neuropathy (CIPN) characteristics and patterns described …

Background The dramatic increase in the number of childhood cancer survivors over the last
60 years has made monitoring and minimising long term side effects of cancer treatment …

Chemotherapy‐induced peripheral neuropathy (CIPN) is a common dose‐limiting side effect
experienced by patients receiving treatment for cancer. Approximately 30 to 40% of patients …

Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect caused by
several classes of widely used anticancer therapeutics. Chemotherapy-induced peripheral …

Chemotherapy-induced peripheral neuropathies (CIPNs) are an increasingly common
neuropathic and pain syndrome in adult and pediatric cancer patients and survivors [1–69] …

Background: Vinca alkaloids and platinum-containing chemotherapeutic drugs have the
potential to cause chemotherapy-induced peripheral neuropathy (CIPN). This study …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of typical
chemotherapeutics among cancer survivors. Despite the recent progress, the effective …

Chemotherapy-induced peripheral neuropathy (CIPN) is the most common off-target
adverse effects caused by various chemotherapeutic agents, such as cisplatin, oxaliplatin …